Bromfenac Inhibits TGF-β1–Induced Fibrotic Effects in Human Pterygium and Conjunctival Fibroblasts
Author(s) -
Kailin Chen,
Kairan Lai,
Xiaobo Zhang,
Zhenwei Qin,
Qiuli Fu,
Chenqi Luo,
Xiuming Jin,
Jianghua Hu,
Siyu Liu,
Ke Yao
Publication year - 2019
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.18-24743
Subject(s) - fibronectin , western blot , transforming growth factor , cell migration , wound healing , cell growth , chemistry , blot , trabecular meshwork , microbiology and biotechnology , cell , ciliary muscle , pharmacology , immunofluorescence , fibroblast , medicine , andrology , in vitro , immunology , endocrinology , biology , ophthalmology , biochemistry , glaucoma , antibody , accommodation , neuroscience , gene
Nonsteroidal anti-inflammatory drugs (NSAIDs) have shown antifibrotic effects on several diseases. The aims of the present in vitro study were to investigate the antifibrotic effects of bromfenac (a kind of NSAID) on primary human pterygium fibroblasts (HPFs) and primary human conjunctival fibroblasts (HConFs), as well as to explore the possible mechanisms of these effects.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom